NORMAL-ANION-GAP METABOLIC ACIDOSIS

✓ Medically ReviewedDISEASEID: MDBT0246🚨 TRIAGE: URGENTICD-10: E87.2

📖

Definition

CLINICAL DEFINITION

A primary acid-base disorder characterised by a decrease in serum bicarbonate concentration and a compensatory decrease in arterial partial pressure of carbon dioxide (PaCO2), with a calculated serum anion gap that remains within the normal reference range (typically 8–12 mEq/L). It is primarily driven by the loss of bicarbonate from the gastrointestinal tract or kidneys, or by a failure of renal acid excretion, accompanied by a reciprocal increase in serum chloride to maintain electroneutrality.

IN PLAIN ENGLISH

A condition where the blood becomes too acidic because the body has lost too much base (bicarbonate) or cannot remove enough acid. Unlike other types of acidosis, the balance of negatively charged particles like chloride shifts to keep the overall electrical charge of the blood normal.

COMMON MISCONCEPTION / WHAT IT DOES NOT MEAN

Normal-Anion-Gap Metabolic Acidosis is NOT high-anion-gap metabolic acidosis (HAGMA), which is caused by the accumulation of unmeasured organic acids (such as lactate or ketones). It is also NOT respiratory acidosis, which is caused by the retention of carbon dioxide due to inadequate ventilation.

🔤

Word Breakdown

acid

=sour or sharp, referring to chemical acids (from Latin 'acidus')

-osis

=abnormal condition or disease process (from Greek '-osis')

Literal Meaning: An abnormal condition of acid in the blood with a normal anion gap arising from metabolic processes

🏷️

Abbreviations

NAGMA=Normal-Anion-Gap Metabolic Acidosis — commonly used in critical care and nephrology

RTA=Renal Tubular Acidosis — a primary cause of NAGMA

🔄

Synonyms & Variants

Hyperchloremic Metabolic Acidosis›Hyperchloraemic Metabolic Acidosis›

🎯

Category-Specific Context

As an acid-base disorder, Normal-Anion-Gap Metabolic Acidosis (NAGMA) represents a specific pathophysiological framework where the primary disturbance is a depletion of bicarbonate buffers. It is classified alongside high-anion-gap metabolic acidosis based on the principle of electroneutrality, where the lost bicarbonate is replaced by chloride, hence the alternative name 'hyperchloraemic metabolic acidosis'.

🏥

Clinical Context & Usage

CLINICAL SETTINGS

Emergency DepartmentIntensive Care UnitNephrology ClinicGeneral Medicine WardGastroenterology Ward

USAGE & DOCUMENTATION NOTES

Clinicians often refer to this simply as "NAGMA" or "hyperchloraemic acidosis" during ward rounds. In arterial blood gas (ABG) and electrolyte interpretation, it is documented when the pH is < 7.35, bicarbonate is low, and the calculated anion gap (Na - [Cl + HCO3]) is ≤ 12 mEq/L. The urine anion gap (Na + K - Cl) is frequently calculated and documented in the notes to differentiate renal from extra-renal causes.

🔬

Primary Causes & Pathophysiology

PATHOPHYSIOLOGY

The fundamental mechanism of NAGMA is a primary reduction in serum bicarbonate (HCO3-) concentration without the addition of unmeasured organic acids. To maintain serum electroneutrality, the decrease in the negatively charged bicarbonate ion is offset by a compensatory increase in the reabsorption of chloride (Cl-) by the kidneys, leading to hyperchloraemia. This bicarbonate deficit arises either from direct losses via the gastrointestinal tract (e.g., severe diarrhoea, pancreatic fistulas) or via the kidneys (e.g., renal tubular acidosis, carbonic anhydrase inhibitors), or from a failure of the kidneys to excrete hydrogen ions (as in Type 4 RTA). The respiratory system compensates by increasing alveolar ventilation to blow off CO2, lowering the PaCO2 according to Winter's formula.

PRIMARY CAUSES

Severe Diarrhoea

Direct loss of bicarbonate-rich fluid from the lower gastrointestinal tract, leading to a compensatory increase in serum chloride.

Renal Tubular Acidosis (Type 1, 2, and 4)

Impaired renal bicarbonate reabsorption (Type 2) or defective distal hydrogen ion secretion (Type 1 and 4), resulting in net acid retention and bicarbonate wasting.

Carbonic Anhydrase Inhibitors (e.g., Acetazolamide)

Blockade of proximal tubular bicarbonate reabsorption, causing profound urinary bicarbonate loss and subsequent hyperchloraemic acidosis.

Pancreatic or Biliary Fistulas

Loss of alkaline pancreatic and biliary secretions, which are normally rich in bicarbonate, into drains or the peritoneal cavity.

Ureterosigmoidostomy or Ileal Conduit

The bowel mucosa exchanges urinary chloride for bicarbonate, leading to systemic bicarbonate depletion and chloride retention.

Early Renal Failure

Mild to moderate reductions in glomerular filtration rate can impair ammonium excretion before the retention of unmeasured uraemic anions (like sulphates and phosphates) becomes significant enough to elevate the anion gap.

💊

Drug-Induced Causes

💊 Carbonic anhydrase inhibitors (acetazolamide, topiramate, zonisamide) ↗

Mechanism: Inhibit proximal tubular bicarbonate reabsorption, causing urinary bicarbonate wasting and a Type 2 (proximal) renal tubular acidosis pattern.

→ Discontinue the offending agent if clinically feasible; consider oral alkali supplementation (e.g., sodium bicarbonate or potassium citrate) to correct the acidosis.

💊 Amphotericin B ↗

Mechanism: Increases distal tubular membrane permeability to hydrogen ions, allowing back-diffusion and impairing net acid excretion, causing a Type 1 (distal) RTA pattern.

→ Monitor electrolytes and acid-base status closely; alkali therapy may be required; consider alternative antifungal agents if acidosis is severe.

💊 Ifosfamide ↗

Mechanism: Causes direct proximal tubular toxicity (Fanconi syndrome), leading to generalized reabsorption defects including bicarbonate wasting.

→ Ensure adequate hydration; supplement bicarbonate and electrolytes; discontinue if severe tubular damage occurs.

💊 Spironolactone, Trimethoprim, Pentamidine ↗

Mechanism: Block the epithelial sodium channel (ENaC) or aldosterone receptors in the collecting duct, mimicking hypoaldosteronism and causing a Type 4 RTA (hyperkalaemic NAGMA).

→ Stop the medication; manage hyperkalaemia; consider fludrocortisone or alkali therapy if acidosis persists.

🌍

Epidemiology

Prevalence:Metabolic acidosis is present in up to 40% of critically ill patients with acute kidney injury. Among metabolic acidoses in the hospital setting, NAGMA accounts for approximately 10–20% of cases, frequently seen in post-operative patients, those with severe diarrhoea, or those on specific medications.

Age Group:Affects all age groups depending on the underlying aetiology: neonates and infants (congenital RTAs, severe infectious diarrhoea), adults (medication-induced, chronic diarrhoea, early CKD), and older adults (Type 4 RTA associated with diabetic nephropathy or polypharmacy).

Sex Predilection:Equal

Geographic Distribution:Globally distributed, but infectious causes of severe diarrhoea (e.g., cholera, rotavirus) leading to NAGMA are disproportionately more common in low- and middle-income countries with limited access to clean water and sanitation.

Red Flags & Triage ★

TRIAGE LEVEL

🚨 URGENT

DO NOT MISS — LIFE-THREATENING PRESENTATIONS

Type 1 (Distal) RTA with severe hypokalaemia — can cause life-threatening respiratory muscle weakness and cardiac arrhythmias; requires urgent potassium replacement before or alongside alkali therapy.
Addisonian crisis (primary adrenal insufficiency) — presents with NAGMA (Type 4 RTA pattern), hyperkalaemia, hyponatraemia, and haemodynamic shock; requires immediate intravenous hydrocortisone and fluid resuscitation.

URGENT EVALUATION TRIGGERS

Arterial pH < 7.10 or serum bicarbonate < 10 mEq/L with signs of haemodynamic instability
Concurrent severe hyperkalaemia (K+ > 6.0 mEq/L) with ECG changes
Profound hypokalaemia (K+ < 2.5 mEq/L) with muscle weakness or arrhythmias

Contraindications & Precautions

CONTRAINDICATIONS

Rapid overcorrection with intravenous sodium bicarbonate in patients with severe hypocalcaemia (alkalinisation can precipitate tetany or seizures by lowering ionised calcium)
Administration of large volumes of sodium bicarbonate in patients with severe volume overload or decompensated heart failure (risk of exacerbating pulmonary oedema)

SPECIAL PRECAUTIONS

Monitor serum potassium closely during alkali therapy
as correcting the acidosis drives potassium intracellularly and can unmask or worsen severe hypokalaemia.
Check ionised calcium levels before administering intravenous bicarbonate
as alkalinisation decreases the ionised fraction of calcium.
Ensure adequate respiratory compensation is possible before administering sedatives or opioids
which could blunt the compensatory hyperventilation and worsen acidaemia.

Complications

DOWNSTREAM CLINICAL COMPLICATIONS

Muscle wasting and bone demineralisation (chronic buffering of acid by bone releases calcium and phosphate
leading to osteomalacia or osteoporosis)
Hypokalaemia (in Type 1 and Type 2 RTA or severe diarrhoea
increasing the risk of cardiac arrhythmias and muscle weakness)
Hyperkalaemia (in Type 4 RTA
posing a risk for life-threatening cardiac conduction abnormalities)
Nephrolithiasis and nephrocalcinosis (particularly in Type 1 RTA due to hypercalciuria
hypocitraturia
and alkaline urine pH)

📏

Reference Ranges

NORMAL RANGEAnion gap: 8–12 mEq/L (or 3–11 mmol/L depending on the assay and whether potassium is included). Serum bicarbonate: 22–28 mEq/L. Arterial pH: 7.35–7.45.

CRITICAL (PANIC) VALUEArterial pH < 7.10 or serum bicarbonate < 10 mEq/L — requires urgent evaluation and potential intravenous alkali therapy or renal replacement therapy, as severe acidaemia impairs myocardial contractility and vascular response to catecholamines.

UNIT OF MEASUREMENTmEq/L (or mmol/L) for anion gap and bicarbonate.

🔀

Confused With (LASA & DDx) ★

LEXICAL (LASA) — SIMILAR NAMES

High-Anion-Gap Metabolic Acidosis (HAGMA)

Both are types of metabolic acidosis, but HAGMA involves the accumulation of unmeasured organic acids (e.g., lactate, ketones) while NAGMA involves bicarbonate loss replaced by chloride.

CLINICAL DIFFERENTIAL DIAGNOSES (DDx)

High-Anion-Gap Metabolic Acidosis

Key Distinguishing Feature: Elevated serum anion gap (> 12 mEq/L) due to the presence of unmeasured anions like lactate, ketones, or toxins; serum chloride is typically normal.

Respiratory Alkalosis with compensatory metabolic acidosis

Key Distinguishing Feature: Primary disturbance is a low PaCO2 with an elevated pH; the low bicarbonate is a compensatory renal response, not a primary acid-base disorder.

Mixed Acid-Base Disorder

Key Distinguishing Feature: Presence of concurrent primary respiratory or metabolic disturbances; requires careful application of Winter's formula and delta-delta calculations to identify.

💎

Clinical Pearls

💎

The urinary anion gap (UAG = Urine Na + Urine K - Urine Cl) is a crucial bedside tool. A negative UAG suggests appropriate renal ammonium excretion (pointing to gastrointestinal bicarbonate loss like diarrhoea), while a positive UAG indicates impaired renal acid excretion (pointing to Renal Tubular Acidosis).

💎

Always calculate the expected respiratory compensation using Winter's formula (Expected PaCO2 = 1.5 × [HCO3-] + 8 ± 2). If the measured PaCO2 is higher than expected, a concurrent respiratory acidosis is present; if lower, a concurrent respiratory alkalosis is present.

💎

In early or mild chronic kidney disease (CKD), patients often develop a normal-anion-gap acidosis due to impaired ammoniagenesis before the retention of unmeasured uraemic anions (sulphates, phosphates) is sufficient to widen the anion gap.

📝

Example Usage & SOAP

CLINICAL SENTENCE

"The patient presents with a normal-anion-gap metabolic acidosis secondary to severe secretory diarrhoea, evidenced by a low serum bicarbonate of 14 mEq/L, a negative urinary anion gap, and appropriate respiratory compensation."

IN A SOAP NOTE

S: 45-year-old male with 3 days of profuse, watery diarrhoea, generalised weakness, and dizziness on standing. O: BP 95/60 mmHg, HR 110 bpm, RR 22 breaths/min, dry mucous membranes, decreased skin turgor. ABG: pH 7.28, PaCO2 26 mmHg, HCO3- 12 mEq/L. BMP: Na 138, K 3.1, Cl 114, HCO3 12, Anion Gap 12. Urine electrolytes: Na 40, K 20, Cl 90 (Urine Anion Gap = -30). A: Normal-anion-gap metabolic acidosis (hyperchloraemic) secondary to severe gastrointestinal bicarbonate loss, with concurrent hypokalaemia and volume depletion. Appropriate respiratory compensation present. P: Aggressive IV fluid resuscitation with isotonic crystalloids. IV potassium chloride replacement. Monitor strict input/output and repeat BMP/ABG in 4 hours. Investigate infectious aetiology of diarrhoea.

DIFFERENTIAL DIAGNOSIS CONTEXT

Differential for normal-anion-gap metabolic acidosis: (1) Gastrointestinal bicarbonate loss (e.g., severe diarrhoea, pancreatic fistula) — typically features a negative urinary anion gap and hypokalaemia. (2) Renal Tubular Acidosis (Type 1 or 2) — features a positive urinary anion gap; Type 1 often has alkaline urine pH > 5.5 and hypokalaemia. (3) Type 4 RTA (hypoaldosteronism) — features a positive urinary anion gap, acidic urine pH < 5.5, and hyperkalaemia. (4) Medication-induced (e.g., acetazolamide) — history of drug exposure.

📈

Prognosis

SHORT-TERM OUTCOME

Highly dependent on the underlying cause and the speed of correction. Acute NAGMA from diarrhoea or medications typically resolves within days with appropriate fluid, electrolyte, and alkali replacement. Severe acidosis (pH < 7.1) can cause transient haemodynamic instability but usually reverses rapidly with treatment.

LONG-TERM PROGNOSIS

Chronic NAGMA (e.g., from untreated RTA or chronic kidney disease) can lead to long-term complications such as growth retardation in children, chronic kidney disease progression, and metabolic bone disease. With appropriate chronic alkali therapy, long-term prognosis is generally excellent.

📚

References & Coding

ICD-10 DIAGNOSTIC CODE

E87.2

LITERATURE CITATIONS & GUIDELINES

[1]Kraut JA, Madias NE. Metabolic acidosis: pathophysiology, diagnosis and management. Nat Rev Nephrol. 2010;6(5):274-285.

[2]Hamm LL, Nakhoul N, Hering-Smith KS. Acid-Base Homeostasis. Clin J Am Soc Nephrol. 2015;10(12):2232-2242.

[3]Berend K, de Vries AP, Gans RO. Physiological approach to assessment of acid-base disturbances. N Engl J Med. 2014;371(15):1434-1445.

MEDICAL DISCLAIMER — This content is intended for educational purposes and qualified healthcare professionals only. Always refer to current clinical diagnostic criteria, institutional protocols, and official guidelines. Medobo is not responsible for clinical decisions made based on this content.